In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp.
- 31 January 2000
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 36 (1) , 49-52
- https://doi.org/10.1016/s0732-8893(99)00107-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristinJournal of Antimicrobial Chemotherapy, 1997
- A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmasJournal of Antimicrobial Chemotherapy, 1997
- The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humansJournal of Antimicrobial Chemotherapy, 1997
- In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested speciesDiagnostic Microbiology and Infectious Disease, 1996
- Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemiaJournal of Antimicrobial Chemotherapy, 1995
- In vitro activity of RP 74501-RP 74502, a novel streptogramin antimicrobial mixture, against clinical isolates of Legionella speciesAntimicrobial Agents and Chemotherapy, 1993
- In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumoniaAntimicrobial Agents and Chemotherapy, 1992
- In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella sppJournal of Antimicrobial Chemotherapy, 1992
- Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophagesJournal of Antimicrobial Chemotherapy, 1992
- In vitro activity of azithromycin against clinical isolates of Legionella speciesAntimicrobial Agents and Chemotherapy, 1991